To receive (if any)

Members are invited to disclose any interests in any of the items on the agenda at this point of the meeting.  Members may still declare an interest in an item at any time prior to the consideration of the matter.

There were no disclousures of interests.

The Chairman will announce details of the arrangements in case of fire or other events that might require the meeting room or building’s evacuation.

The Chairman reminded members of the actions to be taken in case of an emergency.

To approve as a correct record the Minutes of the meetings of the Committee held on 21^st December 2022 and authorise the Chairman to sign them

The minutes of the previous meeting held on 21^st December 2022 were agreed as a correct record and signed by the Chairman.

Report and appendix attached

The Sub-Committee was presented with a BHRUT Update report.

Alongside a presentation as shown in the agenda, it was explained to members that for the past 2 winters, in-patient numbers have not spiked enough for the elective hubs to close which was positive as it is the view that electives should be protected. Members questioned if cancer patients had to wait more than 52 weeks and whether there were plans to reduce the 52+ week waiting list. It was explained that cancer patients have to start treatment in 62 days maximum and that there was a national target to reduce the 52+ week waiting list by March 2025 and a local target of September 2023.

It was explained to members that NEL pathology is the most under resourced service in London with the lowest workforce per 100k population. A staff survey had been held with results showing that staff want to be valued and plans had been put in place to have junior level staff shadow executive level staff to observe the decision making processes within BHRUT. It was noted that no issues had been raised yet regarding the new ULEZ expansion.

The Sub-Committee suggested that space be kept free in the master plan for NHS provisions to which NHS staff would contact the Council to consider.

The Sub-Committee made no other recommendations..